Powering researchers' insights with innovative single cell, spatial biology, & in situ tools
10x Genomics delivers powerful, reliable instruments, reagents, and software for single-cell, spatial, and in situ genomic analysis, enabling researchers to make discoveries across oncology, immunology, and neuroscience. Cited in more than 10,000 research papers, the company has placed 4,600+ instruments at top global institutions and holds 1,750+ patents.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
BridgeBio makes targeted treatments for genetic diseases.